Phase 3 clinical trial of pridopidine in ALS patients likely this year - ALS News Today
alsnewstoday.comSubmitted by alsnewstoday5631 in health
A Phase 2 HEALEY study tied pridopidine to slower progression and better respiration and speech, particularly with early, aggressive disease.